Concentrations of hepatocyte growth factor, basic fibroblast growth factor, and vascular endothelial growth factor in pericardial fluid and plasma

Japanese Heart Journal

Volumn 45, Issue 6, 2004, Pages 989-998

  Kubota, Tetsuya ^a   Namiki, Atsushi ^a   Fukazawa, Masayuki ^a   Ishikawa, Michiro ^a   Moroi, Masao ^a   Ebine, Kunio ^a   Yamaguchi, Tetsu ^a,b  

^a TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TORANOMON HOSPITAL   (Japan)

Author keywords

Basic fibroblast growth factor; Hepatocyte growth factor; Ischemic heart disease; Nonischemic heart disease; Pericardial fluid; Vascular endothelial growth factor

Indexed keywords

ANGIOGENIC FACTOR; ANTITHROMBOCYTIC AGENT; BASIC FIBROBLAST GROWTH FACTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; NITRATE; SCATTER FACTOR; VASCULOTROPIN; FIBROBLAST GROWTH FACTOR 2;

ADULT; ANGIOGENESIS; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; ECHOCARDIOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; MALE; OPEN HEART SURGERY; PATHOPHYSIOLOGY; PERICARDIAL EFFUSION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN SECRETION; PROTEIN SYNTHESIS; STATISTICAL SIGNIFICANCE; STUDENT T TEST; AGED; BLOOD; COLLATERAL CIRCULATION; HEART MUSCLE; HEART MUSCLE ISCHEMIA; METABOLISM; MIDDLE AGED;

AGED; ANGIOGENESIS INDUCING AGENTS; COLLATERAL CIRCULATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROBLAST GROWTH FACTOR 2; HEPATOCYTE GROWTH FACTOR; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; MYOCARDIUM; PERICARDIAL EFFUSION; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 13844306730     PISSN: 00214868     EISSN: None     Source Type: Journal    
DOI: 10.1536/jhj.45.989     Document Type: Article

References (30)

1. Adair TH, Gay WJ, Montani JP. Growth regulation of the vascular system: evidence for a metabolic hypothesis. Am J Physiol 1990; 259: R393-404. (Review)
2. Folkman J, Klagsbrun M. Angiogenic factors. Science 1987; 235: 442-7. (Review)
3. Matsumoto K, Nakamura T. Emerging multipotent aspects of hepatocyte growth factor. J Biochem 1996; 119: 591-600. (Review)
4. Gospodarowicz D, Ferrara N, Schweigerer L, et al. Structural characterization and biological functions of fibroblast growth factor. Endocr Rev 1987; 8: 95-114.
5. Ferrara N, Henzel W. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun 1989; 161: 851-8.
6. Aoyagi M, Yamamoto S, Azuma H, et al. Localization and effects of hepatocyte growth factor on smooth muscle cells during neointimal formation after balloon denudation. Histochem Cell Biol 1999; 111: 419-28.
7. Lazarous DF, Shou M, Scheinowitz M, et al. Comparative effects of basic fibloblast growth factor and vascular endothelial growth factor on coronary collateral development and the arterial response to injury. Circulation 1996; 147: 1649-60.
8. Yanagisawa-Miwa A, Uchida Y, Nakamura F, et al. Salvage of infarcted myocardium by angiogenic action of basic fibroblast growth factor. Science 1992; 257: 1401-3.
9. Takeshita S, Zheng LP, Brogi E, et al. Therapeutic angiogenesis. A single intraarterial bolus vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model. J Clin Invest 1994; 93: 662-70.
10. Tsurumi Y, Takeshita S, Chen D, et al. Direct intramuscular gene transfer of naked DNA encoding vascular endothelial growth factor augments collateral development and tissue perfusion. Circulation 1996; 94: 3281-90.
11. Yang HT, Deschenes MR, Ogilvie RW, Terjung RL. Basic fibroblast growth factor increases collateral blood flow in rats with femoral arterial ligation. Circ Res 1996; 79: 62-9.
12. Morishita R, Nakamura S, Hayashi S, et al. Therapeutic angiogenesis induced by human recombinant hepatocyte growth factor in rabbit hind limb ischemia model as cytokine supplement therapy. Hypertension 1999; 33: 1379-94.
13. Aoki M, Morishita R, Taniyama Y, et al. Angiogenesis induced by hepatocyte growth factor in non-infarcted myocardium and infracted myocardium: up-regulation of essential transcription factor for angiogenesis, ets. Gene Ther 2000; 7: 417-27.
14. Baumgartner I, Pieczek A, Manor O, et al. Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. Circulation 1998; 97: 1114-23.
15. Losordo DW, Vale PR, Symes JF, et al. Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of ph VEGF 165 as sole therapy for myocardial ischemia. Circulation 1998; 98: 2800-4.
16. Udelson JE, Dilsizian V, Laham RJ, et al. Therapeutic angiogenesis with recombinant fibroblast growth factor-2 improves stress and rest myocardial perfusion abnormalities in patients with severe symptomatic chronic coronary artery disease. Circulation 2000; 102: 1605-10.
17. Lazarous DF, Unger EF, Epstein SE, et al. Basic fibroblast growth factor in patients with intermittent claudication: results of a phase I trial. J Am Coll Cardiol 2000; 36: 1239-44.
18. Casscells W, Speir E, Sasse J, et al. Isolation, characterization, and localization of heparin-binding growth factors in the heart. J Clin Invest 1990; 85: 433-41.
19. Shinohara K, Shinohara T, Mochizuki N, et al. Expression of vascular endothelial growth factor in human myocardial infarction. Heart Vessel 1996; 11: 113-22.
20. Yasuda S, Goto Y, Baba T, et al. Enhanced secretion of cardiac hepatocyte growth factor from an infarct region is associated with less severe ventricular enlargement and improved cardiac function. J Am Coll Cardiol 2000; 36: 115-21.
21. Fujita M, Ikemoto M, Kishishita M, et al. Elevated basic fibroblast growth factor in pericardial fluid of patients with unstable angina. Circulation 1996; 94: 610-3.
22. Matsumori A, Furukawa Y, Hashimoto T, et al. Increased circulating hepatocyte growth factor in the early stage of acute myocardial infarction. Biochem Biophys Res Common 1996; 221: 391-5.
23. Morishita R, Aoki M, Nakamura S, et al. Potential role of a novel vascular modulator, hepatocyte growth factor (HGF), in cardiovascular disease: characterization and regulation of local HGF system. J Atheroscler Thromb 1997; 4: 12-9.
24. Corda S, Mebazaa A, Gandolfini MP, et al. Trophic effect of human pericardial fluid on adult cardiac myocytes. Differential role of fibroblast growth factor-2 and factors related to ventricular hypertrophy. Circ Res 1997; 81: 679-87.
25. Yoneda T, Fujita M, Kihara Y, et al. Pericardial fluid from patients with ischemic heart disease accelerates the growth of human vascular smooth muscle cells. Jpn Circ J 2000; 64: 495-8.
26. Uchida Y, Yanagisawa-Miwa A, Nakamura F, et al. Angiogenic therapy of acute myocardial infarction by intrapericardial injection of basic fibroblast growth factor and heparin sulfate: an experimental study. Am Heart J 1995; 130: 1182-8.
27. Tamura K, Nakajima H, Rakue H, et al. Elevated circulating levels of basic fibroblast growth factor and vascular endothelial growth factor in patients with acute myocardial infarction. Jpn Circ J 1999; 63: 357-61.
28. Hojo Y, Ikeda U, Zhu Y, et al. Expression of vascular endothelial growth factor in patients with acute myocardial infarction. J Am Coll Cardiol 2000; 35: 968-73.
29. Fujita M, Ikemoto M, Tanaka T, et al. Marked elevation of vascular endothelial growth factor and basic fibroblast growth factor in pericardial fluid of patients with angina pectoris. Angiogenesis 1998; 2: 105-8.
30. Nakano N, Moriguchi A, Morishita R, et al. Role of angiotensin II in the regulation of a novel vascular modulator, hepatocyte growth factor (HGF), in experimental hypertensive rats. Hypertension 1997; 30: 1448-54.